{"text": "mrk fascinating it would be a mistake for bmy not to buy xlrn"}
{"text": "sweepcast alerted bmy with unusual options activity alerted on 67 5 put expiring 01 21 2022 worth 222k start using sweepcast"}
{"text": "pirs with mrk plucking away xlrn partner bmy will azn with multiple respiratory programs with one in ph2a currently let a genentech roche walk in and take company ph2a azd1402 first dose in march"}
{"text": "bmy u s food and drug administration accepts bristol myers squibbs applications for opdivo nivolumab yervoy ipilimumab and opdivo chemotherapy for unresectable advanced recurrent or metastatic esophageal squamous cell carcinoma"}
{"text": "this is just an absolute dog of a name it seems every year there are well intentioned and researched bull pieces on bmy only for it to lag enormously"}
{"text": "bristol myers squibb company current quarter revenue growth yoy of 15 50 ranked 2314 out of 5597 companies in our database bmy"}
